Louts raises $880 million through SPAC

The 33-year-old Chinese entrepreneur successfully led the start-up CG Oncology to achieve an initial public offering, resulting in a market valuation of nearly 3 billion US dollars specifically for bladder cancer treatment.

The conversion of Kangbaier to NASDAQ is driven by the prevailing trend and the desire to capitalize on it, as well as the potential for success within this trend.

Overview of Chinese companies’ listing in the U.S. in 2023

The IPO market of Chinese concept stocks is recovering, and the willingness of Chinese enterprises to go public overseas is high!

Overview of 2023 Enterprise Listing Data in the United States

Congratulations on the successful convening of the Kangbeier board transfer briefing!

The first VIE structure to be listed overseas! Car technology skyrockets 581%! NASDAQ welcomes Chinese demon stocks!